> top > docs > PubMed:25157153 > annotations

PubMed:25157153 JSONTXT

Annnotations TAB JSON ListView MergeView

PubTator4TogoVar

Id Subject Object Predicate Lexical cue proteinmutation
25157153_0 491-495 ProteinMutation denotes P12A rs1801282

sonoma2

Id Subject Object Predicate Lexical cue
T0 5-13 VAR denotes variants
T1 17-22 GENE denotes PPARG
T2 28-37 NEGREG denotes decreased
T3 38-46 MPA denotes activity
T4 80-90 REG denotes associated
T5 96-105 POSREG denotes increased
T6 121-129 DISEASE denotes diabetes
T7 131-179 GENE denotes Peroxisome proliferator-activated receptor gamma
T8 181-186 GENE denotes PPARG
T9 343-359 NEGREG denotes loss-of-function
T10 361-364 NEGREG denotes LOF
T11 366-375 VAR denotes mutations
T12 379-384 GENE denotes PPARG
T13 398-409 REG denotes cosegregate
T14 415-428 DISEASE denotes lipodystrophy
T15 433-451 DISEASE denotes insulin resistance
T16 433-440 GENE denotes insulin
T17 491-495 NEGREG denotes P12A
T18 496-503 VAR denotes variant
T19 525-534 NEGREG denotes decreased
T20 543-558 DISEASE denotes type 2 diabetes
T21 560-563 DISEASE denotes T2D
T22 587-595 VAR denotes variants
T23 599-604 GENE denotes PPARG
T24 609-616 NEGREG denotes defects
T25 730-735 GENE denotes PPARG
T26 872-877 GENE denotes PPARG
T27 888-891 GENE denotes MAF
T28 1042-1045 DISEASE denotes T2D
T29 1073-1081 MPA denotes function
T30 1092-1100 VAR denotes variants
T31 1221-1228 NEGREG denotes reduced
T32 1229-1237 MPA denotes activity
T33 1279-1282 NEGREG denotes LOF
T34 1283-1291 VAR denotes variants
T35 1296-1306 REG denotes associated
T36 1326-1334 POSREG denotes increase
T37 1346-1349 DISEASE denotes T2D
T38 1521-1528 VAR denotes variant
T39 1532-1537 GENE denotes PPARG
T40 1535-1540 GENE denotes RG th
T41 1543-1550 NEGREG denotes reduces
T42 1551-1559 MPA denotes function
T43 1610-1620 REG denotes associated
T44 1628-1639 POSREG denotes substantial
T45 1648-1651 DISEASE denotes T2D
R23 T30 T31 CauseOf variants,reduced
R24 T32 T31 ThemeOf activity,reduced
R25 T33 T35 CauseOf LOF,associated
R26 T33 T36 CauseOf LOF,increase
R27 T34 T33 CauseOf variants,LOF
R28 T34 T35 CauseOf variants,associated
R38 T45 T44 ThemeOf T2D,substantial
R0 T0 T2 CauseOf variants,decreased
R1 T0 T5 CauseOf variants,increased
R2 T1 T0 ThemeOf PPARG,variants
R3 T3 T2 ThemeOf activity,decreased
R4 T10 T9 CauseOf LOF,loss-of-function
R5 T11 T9 CauseOf mutations,loss-of-function
R6 T11 T10 CauseOf mutations,LOF
R7 T12 T11 ThemeOf PPARG,mutations
R8 T14 T9 ThemeOf lipodystrophy,loss-of-function
R9 T14 T10 ThemeOf lipodystrophy,LOF
R10 T14 T13 ThemeOf lipodystrophy,cosegregate
R11 T14 T19 ThemeOf lipodystrophy,decreased
R12 T15 T9 ThemeOf insulin resistance,loss-of-function
R13 T15 T10 ThemeOf insulin resistance,LOF
R14 T15 T13 ThemeOf insulin resistance,cosegregate
R15 T15 T19 ThemeOf insulin resistance,decreased
R16 T17 T19 CauseOf P12A,decreased
R17 T21 T9 ThemeOf T2D,loss-of-function
R18 T21 T10 ThemeOf T2D,LOF
R19 T21 T13 ThemeOf T2D,cosegregate
R20 T21 T19 ThemeOf T2D,decreased
R21 T22 T24 CauseOf variants,defects
R22 T23 T22 ThemeOf PPARG,variants
R29 T34 T36 CauseOf variants,increase
R30 T37 T33 ThemeOf T2D,LOF
R31 T37 T35 ThemeOf T2D,associated
R32 T37 T36 ThemeOf T2D,increase
R33 T38 T41 CauseOf variant,reduces
R34 T39 T38 ThemeOf PPARG,variant
R35 T42 T41 ThemeOf function,reduces
R36 T45 T41 ThemeOf T2D,reduces
R37 T45 T43 ThemeOf T2D,associated

PubmedHPO

Id Subject Object Predicate Lexical cue
T1 415-428 HP_0009125 denotes lipodystrophy
T2 433-451 HP_0000855 denotes insulin resistance

DisGeNET5_variant_disease

Id Subject Object Predicate Lexical cue
25157153-2#166#170#geners1801282 491-495 geners1801282 denotes P12A
25157153-2#166#170#geners1805192 491-495 geners1805192 denotes P12A
25157153-2#166#170#geners1801282 491-495 geners1801282 denotes P12A
25157153-2#166#170#geners1805192 491-495 geners1805192 denotes P12A
25157153-2#166#170#geners1801282 491-495 geners1801282 denotes P12A
25157153-2#166#170#geners1805192 491-495 geners1805192 denotes P12A
25157153-2#90#103#diseaseC0023787 415-428 diseaseC0023787 denotes lipodystrophy
25157153-2#218#233#diseaseC0011860 543-558 diseaseC0011860 denotes type 2 diabetes
25157153-2#235#238#diseaseC0011860 560-563 diseaseC0011860 denotes T2D
166#170#geners180128290#103#diseaseC0023787 25157153-2#166#170#geners1801282 25157153-2#90#103#diseaseC0023787 associated_with P12A,lipodystrophy
166#170#geners1801282218#233#diseaseC0011860 25157153-2#166#170#geners1801282 25157153-2#218#233#diseaseC0011860 associated_with P12A,type 2 diabetes
166#170#geners1801282235#238#diseaseC0011860 25157153-2#166#170#geners1801282 25157153-2#235#238#diseaseC0011860 associated_with P12A,T2D
166#170#geners180519290#103#diseaseC0023787 25157153-2#166#170#geners1805192 25157153-2#90#103#diseaseC0023787 associated_with P12A,lipodystrophy
166#170#geners1805192218#233#diseaseC0011860 25157153-2#166#170#geners1805192 25157153-2#218#233#diseaseC0011860 associated_with P12A,type 2 diabetes
166#170#geners1805192235#238#diseaseC0011860 25157153-2#166#170#geners1805192 25157153-2#235#238#diseaseC0011860 associated_with P12A,T2D
166#170#geners180128290#103#diseaseC0023787 25157153-2#166#170#geners1801282 25157153-2#90#103#diseaseC0023787 associated_with P12A,lipodystrophy
166#170#geners1801282218#233#diseaseC0011860 25157153-2#166#170#geners1801282 25157153-2#218#233#diseaseC0011860 associated_with P12A,type 2 diabetes
166#170#geners1801282235#238#diseaseC0011860 25157153-2#166#170#geners1801282 25157153-2#235#238#diseaseC0011860 associated_with P12A,T2D
166#170#geners180519290#103#diseaseC0023787 25157153-2#166#170#geners1805192 25157153-2#90#103#diseaseC0023787 associated_with P12A,lipodystrophy
166#170#geners1805192218#233#diseaseC0011860 25157153-2#166#170#geners1805192 25157153-2#218#233#diseaseC0011860 associated_with P12A,type 2 diabetes
166#170#geners1805192235#238#diseaseC0011860 25157153-2#166#170#geners1805192 25157153-2#235#238#diseaseC0011860 associated_with P12A,T2D
166#170#geners180128290#103#diseaseC0023787 25157153-2#166#170#geners1801282 25157153-2#90#103#diseaseC0023787 associated_with P12A,lipodystrophy
166#170#geners1801282218#233#diseaseC0011860 25157153-2#166#170#geners1801282 25157153-2#218#233#diseaseC0011860 associated_with P12A,type 2 diabetes
166#170#geners1801282235#238#diseaseC0011860 25157153-2#166#170#geners1801282 25157153-2#235#238#diseaseC0011860 associated_with P12A,T2D
166#170#geners180519290#103#diseaseC0023787 25157153-2#166#170#geners1805192 25157153-2#90#103#diseaseC0023787 associated_with P12A,lipodystrophy
166#170#geners1805192218#233#diseaseC0011860 25157153-2#166#170#geners1805192 25157153-2#218#233#diseaseC0011860 associated_with P12A,type 2 diabetes
166#170#geners1805192235#238#diseaseC0011860 25157153-2#166#170#geners1805192 25157153-2#235#238#diseaseC0011860 associated_with P12A,T2D

DisGeNET5_gene_disease

Id Subject Object Predicate Lexical cue
25157153-0#17#22#gene5468 17-22 gene5468 denotes PPARG
25157153-0#114#129#diseaseC0011860 114-129 diseaseC0011860 denotes type 2 diabetes
25157153-2#54#59#gene5468 379-384 gene5468 denotes PPARG
25157153-2#90#103#diseaseC0023787 415-428 diseaseC0023787 denotes lipodystrophy
17#22#gene5468114#129#diseaseC0011860 25157153-0#17#22#gene5468 25157153-0#114#129#diseaseC0011860 associated_with PPARG,type 2 diabetes
54#59#gene546890#103#diseaseC0023787 25157153-2#54#59#gene5468 25157153-2#90#103#diseaseC0023787 associated_with PPARG,lipodystrophy

kaiyin_test

Id Subject Object Predicate Lexical cue
T8 343-359 NegReg denotes loss-of-function
T4 366-375 Var denotes mutations
T5 379-384 Gene denotes PPARG
T6 415-428 Disease denotes lipodystrophy
T7 433-451 Disease denotes insulin resistance
T1 491-503 Var denotes P12A variant
T2 525-534 NegReg denotes decreased
T12 543-558 Disease denotes type 2 diabetes
T10 1521-1528 Var denotes variant
T9 1532-1537 Gene denotes PPARG
T11 1543-1550 NegReg denotes reduces
T15 1551-1602 CPA denotes function in a human adipocyte differentiation assay
T13 1610-1620 Reg denotes associated
T14 1648-1651 Disease denotes T2D
R1 T5 T4 ThemeOf PPARG,mutations
R10 T10 T13 CauseOf variant,associated
R11 T14 T13 ThemeOf T2D,associated
R12 T5 T1 ThemeOf PPARG,P12A variant
R2 T4 T8 CauseOf mutations,loss-of-function
R3 T6 T8 ThemeOf lipodystrophy,loss-of-function
R4 T7 T8 ThemeOf insulin resistance,loss-of-function
R5 T1 T2 CauseOf P12A variant,decreased
R6 T12 T2 ThemeOf type 2 diabetes,decreased
R7 T9 T10 ThemeOf PPARG,variant
R8 T10 T11 CauseOf variant,reduces
R9 T15 T11 ThemeOf function in a human adipocyte differentiation assay,reduces

name_no

Id Subject Object Predicate Lexical cue
T8 343-359 NegReg denotes loss-of-function
T4 366-375 Var denotes mutations
T5 379-384 Gene denotes PPARG
T6 415-428 Disease denotes lipodystrophy
T7 433-451 Disease denotes insulin resistance
T1 491-503 Var denotes P12A variant
T2 525-534 NegReg denotes decreased
T12 543-558 Disease denotes type 2 diabetes
T10 1521-1528 Var denotes variant
T9 1532-1537 Gene denotes PPARG
T11 1543-1550 NegReg denotes reduces
T15 1551-1602 CPA denotes function in a human adipocyte differentiation assay
T13 1610-1620 Reg denotes associated
T14 1648-1651 Disease denotes T2D
R1 T5 T4 ThemeOf PPARG,mutations
R10 T10 T13 CauseOf variant,associated
R11 T14 T13 ThemeOf T2D,associated
R12 T5 T1 ThemeOf PPARG,P12A variant
R2 T4 T8 CauseOf mutations,loss-of-function
R3 T6 T8 ThemeOf lipodystrophy,loss-of-function
R4 T7 T8 ThemeOf insulin resistance,loss-of-function
R5 T1 T2 CauseOf P12A variant,decreased
R6 T12 T2 ThemeOf type 2 diabetes,decreased
R7 T9 T10 ThemeOf PPARG,variant
R8 T10 T11 CauseOf variant,reduces
R9 T15 T11 ThemeOf function in a human adipocyte differentiation assay,reduces